Menopause Management - Dr. Barbie Taylor

What happened to menopause care after the controversial Women’s Health Initiative (WHI) study? In this episode, Dr. Barbara “Menopause” Taylor takes a fiery look at how the WHI changed the way women and doctors think about hormone replacement therapy (HRT), examining its findings in relation to heart attack, osteoporosis, Alzheimer’s, and breast cancer.

Dr. Taylor compares menopause management before and afte...

What does “density” really mean—and why can the same word have completely different implications depending on the disease? In this episode, Dr. Barbara “Menopause” Taylor compares density across the heart, bones, brain, breasts, and ovaries, revealing how the concept relates to everything from cholesterol and bone mass to breast tissue and ovarian swellings.

The surprising part? High density can be prot...

What happens when you put four major gynecologic cancers side by side? In this episode, Dr. Barbara “Menopause” Taylor brings together months of lessons on endometrial, cervical, breast, and epithelial ovarian cancer for a revealing game of “Truth or Consequences.” Through 15 questions, she compares risk factors, genetics, screening, diagnosis, treatment, and survival—highlighting where these cancers a...

What happens to your menopause options after you’ve survived epithelial ovarian cancer? In this episode, Dr. Barbara “Menopause” Taylor explores one of the most challenging questions for ovarian cancer survivors: whether hormone replacement therapy (HRT) can still be considered after treatment. She examines the complicated trade-offs between cancer recurrence, estrogen deficiency, long-term health, and quality of ...

Does preventive surgery for ovarian cancer mean giving up your menopause treatment options? In this episode, Dr. Barbara “Menopause” Taylor tackles a question that leaves many women in limbo: what happens to menopause management after risk-reducing surgery for epithelial ovarian cancer?

Dr. Taylor explores whether women with genetic risks, family histories of cancer, or preventive surgeries face special restrictions&mdas...

Which ovarian cancer prevention strategies make the biggest difference—and just how much can they lower your risk? In this episode, Dr. Barbara “Menopause” Taylor compares the full spectrum of options for preventing epithelial ovarian cancer, from surgery and hormonal contraception to lifestyle changes and psychological well-being.

Using the game of limbo as a metaphor, Dr. Taylor breaks down the numbers behind eac...

What do zebras have to do with ovarian cancer? In this episode, Dr. Barbara “Menopause” Taylor takes an unexpected journey into the psychology of health, exploring how chronic stress and depression may influence the risk of epithelial ovarian cancer.

Drawing inspiration from the book Why Zebras Don’t Get Ulcers, Dr. Taylor explains how the human tendency to bounce between overstimulation and emotional exhaustion ca...

What if the secret to staying active isn’t finding the perfect workout, but embracing variety? In this episode, Dr. Barbara “Menopause” Taylor explores how exercise fits into the bigger picture of preventing epithelial ovarian cancer—and why consistency matters more than any single fitness routine.

Drawing on her own lifelong approach to exercise, Dr. Taylor explains the benefits of mixing cardio, strength tr...

Can everyday choices really lower your risk of ovarian cancer? In this episode, Dr. Barbara “Menopause” Taylor explores the lifestyle habits that may influence the development of epithelial ovarian cancer—and why prevention is about much more than genetics.

From diet, alcohol, smoking, exercise, and weight management to the surprising role of talcum powder, Dr. Taylor explains how seemingly ordinary decisions can a...

Can your reproductive choices really influence your risk of ovarian cancer? In this episode, Dr. Barbara “Menopause” Taylor explores the connections between pregnancy, breastfeeding, birth control, and epithelial ovarian cancer prevention.

Dr. Taylor explains how the number of menstrual cycles a woman experiences over her lifetime may affect cancer risk and reveals why factors like multiple pregnancies, extended breastfe...

Should you remove your ovaries during gynecologic surgery—even if you don't have cancer? In this episode, Dr. Barbara “Menopause” Taylor explores one of the most controversial decisions in women's health: elective, opportunistic, and risk-reducing gynecologic surgery.

Dr. Taylor explains how timing, personal risk, and the type of surgery you're already having can influence your options for preventing epithelial ova...

What can women at the highest risk of ovarian cancer do to lower that risk? In this episode, Dr. Barbara “Menopause” Taylor explores the most effective prevention strategies for epithelial ovarian cancer, focusing on women with inherited genetic risk.

Dr. Taylor explains why surgery remains the gold standard for risk reduction, walks through the different surgical options, and compares the benefits and trade-offs of each...

Where does ovarian cancer actually begin—in the ovary or the fallopian tube? In this thought-provoking episode, Dr. Barbara “Menopause” Taylor explores the pathology of serous epithelial ovarian cancer and tackles a question that has sparked major debate in women’s health.

Dedicated to telling the whole story, Dr. Taylor explains how a single study has reshaped medical thinking, influenced treatment decisions...

What happens after an ovarian cancer diagnosis—and why is prognosis for epithelial ovarian cancer so challenging? In this episode, Dr. Barbara “Menopause” Taylor walks through the real-life timeline of this disease, from diagnosis and treatment to recurrence, survival rates, and long-term outcomes.

With her trademark clarity, Dr. Taylor explains why ovarian cancer is often discovered at an advanced stage, why recur...

What does “treatment” really mean when it comes to epithelial ovarian cancer? In this episode, Dr. Barbara “Menopause” Taylor takes listeners behind the scenes of ovarian cancer care, revealing why treatment is often about managing a complex disease rather than achieving a simple cure.

From extensive diagnostic surgery and tumor “debulking” to chemotherapy, clinical trials, and palliative care, Dr...

What do terms like grade, stage, and high-grade serous carcinoma actually mean—and why do they matter so much? In this episode, Dr. Barbara “Menopause” Taylor breaks down the language doctors use to rank epithelial ovarian cancer and explains how these classifications shape treatment, prognosis, and survival.

From microscopic cell behavior to the extent of cancer spread, Dr. Taylor makes sense of a complex topic by...

Why is epithelial ovarian cancer so difficult to diagnose? In this episode, Dr. Barbara “Menopause” Taylor uses the “needle in a haystack” analogy to explain why this cancer is so often discovered late—and why diagnosis can be such a frustrating, high-stakes process.

From vague GI and urinary symptoms to unreliable screening tests and invasive exploratory surgery, Dr. Taylor walks listeners through the ...

What happens when there’s no reliable screening test for one of the deadliest cancers women face? In this episode, Dr. Barbara “Menopause” Taylor explores the complicated world of risk assessment for epithelial ovarian cancer—and why doctors are still struggling to identify which ovarian masses are truly dangerous.

From CA-125 and ultrasound scans to newer tools with names like ROCA and ROMA, Dr. Taylor break...

Why is there still no reliable screening test for ovarian cancer? In this episode, Dr. Barbara “Menopause” Taylor unpacks the frustrating reality of screening for epithelial ovarian cancer—and why detecting it early is far more complicated than most people realize.

Using simple, memorable analogies, Dr. Taylor explains how pelvic exams, ultrasounds, and blood tests like CA-125 all fall short as true screening tools...